Earnings Preview: King Pharmaceuticals

King Pharmaceuticals (KG) is expected to report Q2 earnings before market open Thursday Aug. 7, with a conference call scheduled for 11:00 am ET.

Guidance

Analysts are looking for a profit of 32c on revenue of $397.28M. The consensus is wide, 25c to 37c for EPS, and $361M to $423M for revenue, according to First Call.

Analyst View

In its Q1 earnings release, the company reported EPS of 36c compared to a consensus of 35c and Q1 revenue of $432M compared to a consensus of $452.62. Negative risks to earnings is King Pharmaceuticals' dependence on in-licensing drugs from pharmaceutical companies and continuing pressure from the loss of patent protection on Altace.